2. Categories

      Applications: Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
      Business News: Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
      Technology: Broadband Sources, Doppler, Probes, Tunable Sources
      Miscellaneous: Jobs & Studentships, Student Theses, Textbooks

  3. About Michelson Diagnostics

    Michelson Diagnostics

    Michelson Diagnostics.  Microscopy Systems.  Michelson Diagnostics Ltd (MDL) is a healthcare company providing a live view of cancerous tissue.  The company was formed in March 2006 to develop a hand-held cancer scanner based on an imaging technology called optical coherence tomography (OCT).   The patented device will give clinicians and researchers a live view of sub-surface tissue structures at near-cellular resolution - high enough to see the emergence and growth of cancer. It shows tissue as deep as 2 mm and offers much higher image resolution than ultrasound or MRI.  The non-invasive cancer scan reduces the need for painful and costly biopsies and provides patients and doctors with immediate results. Whole organs can be systematically scanned for abnormalities.

  5. Quotes about Michelson Diagnostics

    1. “ I found the MedTech Tour Summit extremely useful: the high standard of presenting companies at different stages of their business development provided insights into how I need to position Michelson Diagnostics for an investment. I also made contact with several interested investors and advisors, and discussions are progressing. ”
      Jon Holmes in Michelson Diagnostics is Singled Out for Growth
    2. “ Michelson Diagnostics has applied their outstanding technology to forward thinking products and I am extremely pleased to be representing the company in the US. ”
      Kevin C. Oakley in Michelson Diagnostics Opens US Offices And Appoints US Business Development Manager
    3. “ This is a remarkable milestone for Michelson Diagnostics, as it shows, through a statistically significant sample, that multi-beam OCT technology has the potential to play an important role in the early diagnosis of cancer. ”
      Jon Holmes in Michelson Diagnostics Reports First Quantitative Results on Cancer Diagnosis Using Multi-beam OCT imaging

  1. Michelson Diagnostics

    0 Comments Leave a Comment

    1-15 of 141 // 1 2 3 4 5 6 7 8 9 10 »

    1. Mentioned In 141 Articles

    2. Monitoring sinew contraction during formation of tissue-engineered fibrin-based ligament constructs

      Explore Mary Ann Liebert, Inc. publishers (Mar 30 2012)

      Monitoring sinew contraction during formation of tissue-engineered fibrin-based ligament constructs The ability to study the gross morphological changes occurring during tissue formation is vital to producing tissue-engineered structures of clinically relevant dimensions in vitro. Here, we have used non-destructive methods of digital imaging and optical coherence tomography to monitor the early-stage formation and subsequent maturation of fibrin-based tissue-engineered ligament constructs. In addition, the effect of supplementation with essential promoters of collagen synthesis, ascorbic acid (AA) and proline (P), have been ... (Read Full Article)

      Mentions:   Michelson Diagnostics   Daniel Woods

    3. Michelson Diagnostics announces £607k ($952k) investment to drive sales growth of revolutionary skin cancer scanner

      Explore Optical Coherence Tomography News (Mar 13 2012) Dermatology , Oncology , Funding , Other Business News

      Michelson Diagnostics announces £607k ($952k) investment to drive sales growth of revolutionary skin cancer scanner ...vidual investors. Octopus was advised by Shoosmiths (Legal) and Mayfield Consulting (financial DD). Michelson Diagnostics was advised by Rawlison Butler (Legal) About Michelson Diagnostics Ltd: Michelson Diagnostics is a rapidly growing medical device company which has developed and brought to market a scanning de... (Read Full Article)

      Mentions:   Michelson Diagnostics   Jon Holmes   FDA

    4. Advances in Diagnosing Non-melanoma Skin Cancers

      Explore Skin & Aging (Feb 9 2012) Dermatology , Oncology

      Advances in Diagnosing Non-melanoma Skin Cancers Biopsy remains the gold standard, but newer tools are useful adjuncts. More than 3.5 million skin cancers are diagnosed in more than 2 million patients in the United States each year, 1 and evidence from the American Academy of Dermatology (AAD) suggests that 20% of Americans will develop skin cancer. Basal cell and squamous cell carcinomas (BCC and SCC, respectively) are the two most common forms, accounting for about ... (Read Full Article)

      Mentions:   Michelson Diagnostics   Mount Sinai School of Medicine   FDA

    5. Determining The Extent Of A Structure On Or In The Skin Of A Subject

      Explore wipo.int (Feb 9 2012) Dermatology , Oncology , Patents

      Determining The Extent Of A Structure On Or In The Skin Of A Subject A method of and determining the extent of a structure (1), such as a non- melanoma skin cancer, in or on the skin of a subject, the method comprising the steps of: placing an index marker (3) on the skin adjacent to the structure (1); positioning an optical coherence tomography device (8) relative to the index marker; using the optical coherence tomography device (8) to image the structure (1) so ... (Read Full Article)

      Mentions:   Michelson Diagnostics   Jon Holmes   Gordon Mckenzie

    6. Feature Of The Week 2/5/12: Queen Mary University of London Researchers Investigate Quantitative Analysis of OCT and Histopathology Images of Normal and Dysplastic Oral Mucosal Tissues

      Explore Optical Coherence Tomography News (Feb 5 2012) Dentistry

      Feature Of The Week 2/5/12: Queen Mary University of London Researchers Investigate Quantitative Analysis of OCT and Histopathology Images of Normal and Dysplastic Oral Mucosal Tissues Selecting the most representative site for biopsy is crucial in establishing a definitive diagnosis of oral epithelial dysplasia. The current process involves clinical examination that can be subjective and prone to sampling errors. The aim of this study was therefore to investigate the use of optical coherence tomography (OCT) for differentiation of normal and dysplastic oral epithelial samples, with a view to developing an objective and reproducible approach for biopsy ... (Read Full Article)

      Mentions:   University of London   Michelson Diagnostics   University College London

    7. Feature Of The Week 1/8/12: Ultrafast Processing and Rendering of OCT Data using a GPU

      Explore Optical Coherence Tomography News (Jan 8 2012)

      Feature Of The Week 1/8/12: Ultrafast Processing and Rendering of OCT Data using a GPU Processing of the large volumetric data is the bottleneck of the current FD-OCT systems. Solving this issue enables real time visualisation. Various groups have applied utilising the full power of GPU for OCT data processing allows to realise the full potential of OCT. GPU based data processing to OCT. Here we present a GPU-CPU based processing methodology as well evaluates the performance of various GPUs.In standard processing, interference data ... (Read Full Article)

      Mentions:   University of London   Michelson Diagnostics   Pete H. Tomlins

    8. Professor Julia Welzel hosts 1st International Optical Coherence Tomography User Meeting

      Explore Optical Coherence Tomography News (Nov 17 2011) Dermatology

      Professor Julia Welzel hosts 1st International Optical Coherence Tomography User Meeting Michelson Diagnostics Press Release - Optical Coherence Tomography, a non-invasive, real-time optical imaging modality, i......ikum-augsburg.de -- or -- Dr Gordon McKenzie: gordon.mckenzie@md-ltd.co.uk at Michelson Diagnostics Ltd. www.michelsondiagnostics.com Ref: 1. T. Gambichler, V. Jaedicke & S. Terras (2011) ... (Read Full Article)

      Mentions:   Michelson Diagnostics   Mette Mogensen   Gordon Mckenzie

    9. Michelson Diagnostics announces £1.912M investment to drive sales growth of revolutionary skin cancer scanner

      Explore Optical Coherence Tomography News (Nov 9 2011) Dermatology , Funding , Other Business News

      Michelson Diagnostics announces £1.912M investment to drive sales growth of revolutionary skin cancer scanner ...rs.   Octopus was advised by Shoosmiths (Legal) and Mayfield Consulting (financial DD).   Michelson Diagnostics was advised by Rawlison Butler (Legal) and KDS Associates (commercial DD).   References:   ... (Read Full Article)

      Mentions:   Michelson Diagnostics   Jon Holmes   Michelson Diagnostics Vivosight

    10. New tool helps non-melanoma patients avoid surgery (video)

      Explore wcax.com (Oct 28 2011) Dermatology , Oncology

      New tool helps non-melanoma patients avoid surgery (video) Over 13 million Americans have recurring history of non-melanoma skin cancer. They often have scarring from biopsies and surgery. But new technology is helping to change that. A recent biopsy found skin cancer in Patrice Mollica's lower lip. she thought she would need surgery to remove it. "So I knew what the procedure was gonna be and because of the location I knew there would be scarring, so that ... (Read Full Article)

      Mentions:   Michelson Diagnostics   FDA   Michelson Diagnostics Vivosight

    11. Evaluating the use of optical coherence tomography for the detection of epithelial cancers in vitro

      Explore SPIE Digital Library (Oct 27 2011) Dermatology , Oncology , Otolaryngology

      Evaluating the use of optical coherence tomography for the detection of epithelial cancers in vitro Optical coherence tomography (OCT) is a noninvasive imaging methodology that is able to image tissue to depths of over 1 mm. Many epithelial conditions, such as melanoma and oral cancers, require an invasive biopsy for diagnosis. A noninvasive, real-time, point of care method of imaging depth-resolved epithelial structure could greatly improve early diagnosis and long-term monitoring in patients. Here, we have used tissue-engineered (TE) models of normal skin and oral ... (Read Full Article)

      Mentions:   Michelson Diagnostics   Thorlabs   University of Sheffield

    12. OPTICAL COHERENCE TOMOGRAPHY/BIOIMAGING: One decade and $500M: The impact of federal funding on OCT - Part 2

      Explore BioOptics World (Oct 19 2011)

      OPTICAL COHERENCE TOMOGRAPHY/BIOIMAGING: One decade and $500M: The impact of federal funding on OCT - Part 2 ..., which receives government funding. Has received ~$3.2M in direct and indirect government funding. Michelson Diagnostics Dermatology Startup Small ~$7.5M Supported by ~$800K from U.K. government over several years. Licen... (Read Full Article)

      Mentions:   University of Toronto   Massachusetts Institute of Technology   Tomophase Corporation

    13. Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery

      Explore karger.com (Oct 4 2011) Dermatology

      Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery Optical coherence tomography (OCT) has potential as a modality for in vivo imaging of non-melanoma skin cancer (NMSC). By allowing identification of sub-surface margins of NMSC lesions, the use of OCT could improve the rate of complete excision and reduce the average number of stages during Mohs micrographic surgery (MMS). The objective of this study was to use OCT to delineate the apparent sub-surface margins of NMSC lesions prior to ... (Read Full Article)

      Mentions:   University of Pittsburgh   Michelson Diagnostics   Michelson Diagnostics Vivosight

    14. Video on Michelson Diagnostics Vivosight Scanner In Use at a Dermatology Clinic as Seen on WABC News New York

      Explore Optical Coherence Tomography News (Sep 28 2011) Dermatology , Other Business News

      Video on Michelson Diagnostics Vivosight Scanner In Use at a Dermatology Clinic as Seen on WABC News New York The Michelson Diagnostics Vivosight scanner was recently featured on WABC News in New York. A copy of a text article can be ... (Read Full Article)

      Mentions:   Michelson Diagnostics   Michelson Diagnostics Vivosight   Erin Gilbert

    15. New tool to help identify skin cancers

      Explore ABC Owned Television Stations (Sep 28 2011) Dermatology , Other Business News

      New tool to help identify skin cancers NEW YORK (WABC) -- Summer is over, but now is when those new spots come up on the skin, leaving people worried and asking is it cancer? Now there's a new tool that's helping doctors answer that question right in their office. After having skin cancer three times Amanda Bosca wants to make sure the two new dots on her face are not cancer. Related Content More: Get Health ... (Read Full Article)

      Mentions:   Michelson Diagnostics   FDA   Michelson Diagnostics Vivosight

    16. Multiple beam source for a multi-beam interferometer and multi-beam interferometer

      Explore uspto.gov (Sep 27 2011) Patents , Probes

      Multiple beam source for a multi-beam interferometer and multi-beam interferometer A multi-beam interferometer, typically for use in Optical Coherence Tomography, comprising a multiple beam source, the source being arranged so as to provide, in use, a plurality of beams of light for use in the interferometer, the source comprising: a light source arranged to, in use, emit a beam of light; and a rattle plate comprising a first reflective surface and a second reflective surface facing one another, the second ... (Read Full Article)

      Mentions:   Michelson Diagnostics   Jon Holmes

    17. 1-15 of 141 // 1 2 3 4 5 6 7 8 9 10 »